3 German Growth Stocks With High Insider Ownership Growing Earnings At 54%
In This Article:
As the German economy faces a forecasted contraction in 2024, with factory orders experiencing a significant decline, investors are increasingly focused on identifying resilient opportunities within the market. In this context, growth companies with high insider ownership can be particularly appealing, as they often demonstrate strong alignment between management and shareholder interests and have the potential to capitalize on any economic rebound.
Top 10 Growth Companies With High Insider Ownership In Germany
| Name | Insider Ownership | Earnings Growth |
| Stemmer Imaging (XTRA:S9I) | 25.1% | 23.2% |
| Multitude (XTRA:E4I) | 31% | 20.7% |
| Exasol (XTRA:EXL) | 25.3% | 117.1% |
| Deutsche Beteiligungs (XTRA:DBAN) | 39.6% | 54.1% |
| pferdewetten.de (XTRA:EMH) | 20.6% | 97.9% |
| adidas (XTRA:ADS) | 16.6% | 40.4% |
| Alelion Energy Systems (DB:2FZ) | 37.4% | 106.6% |
| R. STAHL (XTRA:RSL2) | 37.9% | 59.3% |
| Friedrich Vorwerk Group (XTRA:VH2) | 18.8% | 24.6% |
| Redcare Pharmacy (XTRA:RDC) | 17.4% | 54.3% |
Underneath we present a selection of stocks filtered out by our screen.
Deutsche Beteiligungs
Simply Wall St Growth Rating: ★★★★★☆
Overview: Deutsche Beteiligungs AG is a private equity and venture capital firm that focuses on direct and fund of fund investments, with a market cap of €461.42 million.
Operations: The company's revenue is derived from Fund Investment Services, generating €48.00 million, and Private Equity Investments, contributing €27.01 million.
Insider Ownership: 39.6%
Earnings Growth Forecast: 54.1% p.a.
Deutsche Beteiligungs AG shows potential for growth with earnings forecasted to increase by 54.07% annually, outpacing the German market. Despite a significant drop in recent earnings and revenue, the company is trading at 62% below its estimated fair value, suggesting possible undervaluation. Revenue growth expectations are strong at 41.7% per year, though profit margins have decreased significantly from last year. The dividend yield of 3.98% is not well covered by current earnings or free cash flows.
Redcare Pharmacy
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Redcare Pharmacy NV operates as an online pharmacy in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market cap of approximately €2.95 billion.
Operations: The company generates revenue from its DACH segment, amounting to €1.74 billion, and its International segment, contributing €391 million.